<DOC>
	<DOCNO>NCT01068262</DOCNO>
	<brief_summary>This study test weight average inhibition u-NTx/Cre ( aminoterminal crosslinked telopeptide Type 1 collagen ) AUC ( 0-168 hour ) Odanacatib</brief_summary>
	<brief_title>Safety Tolerability Odanacatib ( 0822-059 )</brief_title>
	<detailed_description />
	<mesh_term>Osteoporosis</mesh_term>
	<criteria>male subject age 50 75 year ; post menopausal female subject age 45 75 year Subject good general health Subject evidence metabolic bone disorder osteopenia osteoporosis Subject nonsmoker Subject work night shift unable avoid nightshift work study Subject major surgery , donate blood participate another investigational study past 4 week Subject history stroke , chronic seizure , major neurological disease Subject history cancer Subject consume excessive amount alcohol caffeine</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>April 2015</verification_date>
</DOC>